| Identification | Back Directory | [Name]
2{[(5Z)2(1,2diazinan1yl)4oxo4,5dihydro1,3thiazol5ylidene]Methyl}5fluorophenyl pyrrolidine1carboxylate | [CAS]
1181083-81-7 | [Synonyms]
CLP-290
CLP 290;CLP290
[5-Fluoro-2-[(Z)-(2-hexahydropyridazin-1-yl-4-oxo-thiazol-5-ylidene)methyl]phenyl] pyrrolidine
2-([(5Z)-2-(1,2-DIAZINAN-1-YL)-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-5-YLIDENE]METHYL)-5-FLUOROPHENYL PYRROL
2{[(5Z)2(1,2diazinan1yl)4oxo4,5dihydro1,3thiazol5ylidene]Methyl}5fluorophenyl pyrrolidine1carboxylate
(Z)-5-Fluoro-2-((4-oxo-2-(tetrahydropyridazin-1(2H)-yl)thiazol-5(4H)-ylidene)methyl)phenyl pyrrolidine-1-carboxylate
1-Pyrrolidinecarboxylic acid, 5-fluoro-2-[(Z)-[4-oxo-2-(tetrahydro-1(2H)-pyridazinyl)-5(4H)-thiazolylidene]methyl]phenyl ester | [EINECS(EC#)]
604-604-1 | [Molecular Formula]
C19H21FN4O3S | [MDL Number]
MFCD28166314 | [MOL File]
1181083-81-7.mol | [Molecular Weight]
404.46 |
| Chemical Properties | Back Directory | [Boiling point ]
553.7±60.0 °C(Predicted) | [density ]
1.47±0.1 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,2-8°C | [solubility ]
DMSO:23.74(Max Conc. mg/mL);58.7(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:6):1.0(Max Conc. mg/mL);2.47(Max Conc. mM)
DMF:1.0(Max Conc. mg/mL);2.47(Max Conc. mM)
Ethanol:2.02(Max Conc. mg/mL);4.99(Max Conc. mM) | [form ]
A crystalline solid | [pka]
1.29±0.20(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
CLP-290 is a chloride extrusion enhancer. | [in vivo]
CLP290 (oral gavage; 100 mg/kg; twice a day; 7 day) enhances KCC2 activity and restores Cl- transport in superficial dorsal horn (SDH) neurons of morphine-treated rats, and prevents morphine-induced hyperalgesia (MIH) in rat[1]. | Animal Model: | Adult male rats (300?g, >postnatal day 60)[1] | | Dosage: | 100 mg/kg | | Administration: | Oral gavage; 100 mg/kg; twice a day; 7day | | Result: | Rescued established MIH and prevented its development by restoring Cl-?transport or preventing its deficiency in the SDH.
|
| [storage]
Store at -20°C |
|
|